Ποια είναι η τιμή για Sangamo Therapeutics, Inc. (GBY)

Η τιμή για Sangamo Therapeutics, Inc. (GBY) είναι $5.21

Ποια είναι η κεφαλαιοποίηση αγοράς για Sangamo Therapeutics, Inc. (GBY)

Η κεφαλαιοποίηση αγοράς για Sangamo Therapeutics, Inc. (GBY) είναι $745.49M

Sangamo Therapeutics, Inc. (GBY) Τιμή και Κεφαλαιοποίηση Αγοράς

Sangamo Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing genomic medicines designed to significantly improve patients' lives. The company employs cutting-edge platform technologies, including gene therapy, cell therapy, genome editing, and genome regulation. Central to their technological approach is the zinc finger protein (ZFP) platform, which provides both ZFP nucleases for precise DNA sequence modification (allowing for gene addition or knockout) and ZFP transcription factors for upregulating or downregulating gene expression. Their development pipeline includes SB-525, currently in a Phase III AFFINE clinical trial for hemophilia A; ST-920, a gene therapy in Phase I/II STAAR trials for Fabry disease; and SAR445136, a cell therapy undergoing Phase I/II PRECIZN-1 trials for sickle cell disease. Additionally, Sangamo is advancing TX200, a chimeric antigen receptor for HLA-A2 mismatched kidney transplant rejection; KITE-037, a cell therapy targeting cancer; ST-501 for tauopathies; and ST-502 for synucleinopathies, which include Parkinson's disease and other neuromuscular disorders. The company maintains extensive collaborative and strategic partnerships with prominent organizations such as Biogen MA, Inc., Pfizer Inc., Sanofi S.A., Novartis Institutes for BioMedical Research, Inc., and F. Hoffmann-La Roche Ltd. Originally incorporated in 1995 as Sangamo BioSciences, Inc., the company adopted its current name in January 2017 and is headquartered in Brisbane, California.

Η τιμή για GBY	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$36,781.45 $745.49M	NVDA	$5.264T	+705,994.68%
$32,850.33 $745.49M	AAPL	$4.701T	+630,528.67%
$29,188.17 $745.49M	GOOG	$4.177T	+560,226.20%
$26,674.22 $745.49M	MSFT	$3.817T	+511,965.80%
$20,028.63 $745.49M	AMZN	$2.866T	+384,390.13%

Η τιμή για GBY

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$36,781.45 $745.49M